Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01816997Phase 4Unknown
Phase 4, randomised trial of rosuvastatin in hypercholesterolemia (3 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Glucose homeostasis at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01816997.